SEC Form 4 · accession 0001645627-17-000121
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 19, 2017
Accepted (ET)
Sep 21, 2017 · 3:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 19, 2017 | P | 5,000 | $0.026 | A | 23,491,189 | D | |
| Common Stock | Sep 19, 2017 | P | 5,000 | $0.026 | A | 23,496,189 | D | |
| Common Stock | Sep 19, 2017 | P | 5,000 | $0.026 | A | 23,501,189 | D | |
| Common Stock | Sep 19, 2017 | P | 5,000 | $0.0257 | A | 23,506,189 | D | |
| Common Stock | Sep 20, 2017 | P | 5,000 | $0.0252 | A | 23,511,189 | D | |
| Common Stock | Sep 20, 2017 | P | 5,000 | $0.0287 | A | 23,516,189 | D | |
| Common Stock | Sep 20, 2017 | P | 5,000 | $0.0286 | A | 23,521,189 | D | |
| Common Stock | Sep 21, 2017 | P | 5,000 | $0.0285 | A | 23,526,189 | D |
Table II — derivative securities
No Table II lines on this filing.